Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer - Related Studies

Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer

This study is ongoing, but not recruiting participants.

Study NCT00003717. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Prostate Cancer

2	Additional conditions recognized in this trial
		Prostatic Neoplasms

3	More general conditions related to this trial
		Genital Diseases, Male
		Genital Neoplasms, Male
		Neoplasms
		Neoplasms by Site
		Prostatic Diseases
		Urogenital Neoplasms

4	Interventions listed in this trial
		estramustine phosphate sodium
		paclitaxel

5	Additional drug interventions recognized in this trial
		Estramustine

6	More general drug interventions related to this trial
		Alkylating Agents
		Antimitotic Agents
		Antineoplastic Agents
		Antineoplastic Agents, Alkylating
		Antineoplastic Agents, Hormonal
		Antineoplastic Agents, Phytogenic
		Mitosis Modulators
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Therapeutic Uses
		Tubulin Modulators

7	Sponsors listed in this trial
		St. Barnabas Medical Center